[Associations of serum neuromarkers with clinical features of Parkinson's disease].
M A NikitinaEkaterina S KorolevaN G BrazovskayaAnastasiia S BoikoLyudmila A LevchukSvetlana A IvanovaValentina M AlifirovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)
The possibility of using serum proteins of the neurotrophin subfamily and the protein associated with autophagy, cathepsin D, as biomarkers that determine the prognosis of PD, is considered.